Aluma Endovascular Systems

Company Overview

Snapshot

Founded in August 2025 by Ori Kanner, Aluma Endovascular Systems operates with 1–10 employees. The company has secured funding across two rounds from Peregrine Ventures, with its most recent funding round occurring in October 2025.

Business overview

Aluma Endovascular Systems develops advanced laser energy delivery systems featuring proprietary fiber technology integrated into catheters. This technology is designed to deliver highly localized, high-energy laser pulses to targeted areas, addressing power limitations in existing solutions. The company focuses on treating chronic diseases in small arteries, a medical need affecting millions of patients with limited treatment options. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Medical Treatment & Therapeutics, Aluma leverages expertise from collaborations with Elbit Systems and Shaare Zedek Scientific Ltd. to blend technological and clinical innovation.

Company Intelligence Q&A

When was Aluma Endovascular Systems founded?

Aluma Endovascular Systems was founded in August 2025.

Who are the founders of Aluma Endovascular Systems?

Ori Kanner is a Co-Founder and CEO of Aluma Endovascular Systems.

What is Aluma Endovascular Systems' primary focus?

Aluma Endovascular Systems focuses on developing advanced laser energy delivery systems with proprietary fiber technology integrated into catheters, targeting chronic diseases in small arteries.

Which investor participated in Aluma Endovascular Systems' funding rounds?

Peregrine Ventures participated in Aluma Endovascular Systems' funding rounds in September and October 2025.

What is the product stage of Aluma Endovascular Systems?

Aluma Endovascular Systems is currently in the R&D product stage, as of October 2025, following its seed funding rounds.